Wroblewski John J, Sanchez-Buenfil Ermilo, Inciarte Miguel, Berdia Jay, Blake Lewis, Wroblewski Simon, Patti Alexandria, Suter Gretchen, Sanborn George E
Retina Care International, Hagerstown, MD, USA.
Cumberland Valley Retina Consultants, Hagerstown, MD, USA.
J Diabetes Sci Technol. 2025 Mar;19(2):370-376. doi: 10.1177/19322968231194644. Epub 2023 Aug 29.
To compare the performance of Medios (offline) and EyeArt (online) artificial intelligence (AI) algorithms for detecting diabetic retinopathy (DR) on images captured using fundus-on-smartphone photography in a remote outreach field setting.
In June, 2019 in the Yucatan Peninsula, 248 patients, many of whom had chronic visual impairment, were screened for DR using two portable Remidio fundus-on-phone cameras, and 2130 images obtained were analyzed, retrospectively, by Medios and EyeArt. Screening performance metrics also were determined retrospectively using masked image analysis combined with clinical examination results as the reference standard.
A total of 129 patients were determined to have some level of DR; 119 patients had no DR. Medios was capable of evaluating every patient with a sensitivity (95% confidence intervals [CIs]) of 94% (88%-97%) and specificity of 94% (88%-98%). Owing primarily to photographer error, EyeArt evaluated 156 patients with a sensitivity of 94% (86%-98%) and specificity of 86% (77%-93%). In a head-to-head comparison of 110 patients, the sensitivities of Medios and EyeArt were 99% (93%-100%) and 95% (87%-99%). The specificities for both were 88% (73%-97%).
Medios and EyeArt AI algorithms demonstrated high levels of sensitivity and specificity for detecting DR when applied in this real-world field setting. Both programs should be considered in remote, large-scale DR screening campaigns where immediate results are desirable, and in the case of EyeArt, online access is possible.
比较Medios(离线)和EyeArt(在线)人工智能(AI)算法在远程外展现场环境中,使用智能手机眼底摄影捕获的图像上检测糖尿病视网膜病变(DR)的性能。
2019年6月在尤卡坦半岛,使用两部便携式Remidio手机眼底相机对248名患者进行DR筛查,其中许多患者患有慢性视力障碍,并对获得的2130张图像进行回顾性分析,由Medios和EyeArt进行分析。筛查性能指标也通过将掩盖图像分析与临床检查结果相结合作为参考标准进行回顾性确定。
共有129名患者被确定患有某种程度的DR;119名患者没有DR。Medios能够评估每一位患者,其灵敏度(95%置信区间[CI])为94%(88%-97%),特异性为94%(88%-98%)。主要由于摄影师的误差,EyeArt评估了156名患者,其灵敏度为94%(86%-98%),特异性为86%(77%-93%)。在对110名患者的直接比较中,Medios和EyeArt的灵敏度分别为99%(93%-100%)和95%(87%-99%)。两者的特异性均为88%(73%-97%)。
Medios和EyeArt AI算法在这种实际现场环境中应用时,对检测DR具有较高的灵敏度和特异性。在需要即时结果的远程大规模DR筛查活动中,以及对于EyeArt这种可以在线访问的情况,这两种程序都应予以考虑。